Lebrikizumab

Records for this ingredient, by country (identity only).

ATC D11AH10 · 12 markets · 19 records

Lebrikizumab 12 markets · 19 records Forms
Filters
MarketUS 2GB 2CA 2AU 2ES 2JP 2FR 2SG 1MX 1TW 1HK 1EU 1

US 2 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

GB 2 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 250 mg/2 mLinjectionEbglyss 250mg/2ml solution for injection pre-filled pensEbglyss 250mg/2ml solution for injection pre-filled syringes also in US·JP·FR
    +1Other 1 marketsSG

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 125 mg/mL per mL / per unit basis not statedinjectionEBGLYSS lebrikizumab 250 mg/2 mL solution for injection autoinjector (pre-filled pen) unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 2 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

JP 2 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 250 mg/2 mLinjectionイブグリース皮下注250mgオートインジェクターイブグリース皮下注250mgシリンジ also in US·GB·FR
    +1Other 1 marketsSG

FR 2 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 250 mg/2 mLinjectionEBGLYSS 250 mg, solution injectable en seringue préremplieEBGLYSS 250 mg, solution injectable en stylo prérempli also in US·GB·JP
    +1Other 1 marketsSG

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS ×3異可適注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS SOLUTION FOR INJECTION IN PRE-FILLED PEN 250MG/2ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名EBGLYSS ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.